免費咨詢(xún)熱線(xiàn)：
15522676233
拉羅替尼 Larotrectinib Larotrectinib, also known as ARRY-470 and LOXO-101, is an orally bioavailable, potent, ATP-competitive inhibitor of TRKA, TRKB, and TRKC.
更新時(shí)間：2023-07-12
廠(chǎng)商性質(zhì)：代理商
恩曲替尼 Entrectinib Entrectinib, also known as RXDX-101 and NMS-E628, is an oral small molecule inhibitor of TrkA, TrkB and TrkC, as well as ROS1 and ALK, with high potency and selectivity.
更新時(shí)間：2023-07-12
廠(chǎng)商性質(zhì)：代理商
Temsirolimus is an ester analog of rapamycin. It binds to and inhibits the mammalian target of rapamycin (mTOR),
更新時(shí)間：2023-07-12
廠(chǎng)商性質(zhì)：代理商
依維莫司 Everolimus Everolimus, also known as RAD001, is a derivative of the natural macrocyclic lactone sirolimus with immunosuppressant and anti-angiogenic properties.
更新時(shí)間：2023-07-12
廠(chǎng)商性質(zhì)：代理商
曲美替尼 Trametinib Trametinib, also known as GSK1120212, is a n orally bioavailable inhibitor of mitogen-activated protein kinase kinase (MEK MAPK/ERK kinase) with potential antineoplastic activity.
更新時(shí)間：2023-07-12
廠(chǎng)商性質(zhì)：代理商
微信掃一掃
